Interested to know what's your rationale. I would argue just the opposite. I'll grant you that drug compounds are highly risky and unpredictable generally, but there's a lot of evidence suggesting that these compounds specifically, LymPro, MANF, and eltoprazine, are all effective and safe. If just one makes it to market, especially MANF, the upside is tremendous.
It may drift up or down a bit while we wait, but with what we know it seems like this is the bottom and it could explode at any time.
News 
Market Data 
Discover 
AI
